Ireland
--:--IST
Latest
Clinical Trials in France / NCT06820892
Recruiting Observational

Quality of Information Provided During Antenatal Consultations

NCT06820892 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2024-08-02
Last updated
2025-02-11

Condition(s) studied

Congenital AnomaliesPrematurityAntenatal Consultation

Investigational drug(s) / intervention(s)

Survey

Survey: The study utilised a 16-item questionnaire to evaluate the quality of information received during antenatal diagnosis consultations and its congruence with subsequent experiences following birth and hospitalisation of the infant. The questionnaire encompassed seven questions pertaining to consultation arrangements, including duration, frequency and unit visits, six questions addressing the received information, and three questions exploring the long-term outcomes of the child.

Study summary

The objective of this questionnaire study is to evaluate the concordance between the information provided to parents during antenatal consultations and their subsequent experiences following childbirth.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients were observed at the multidisciplinary prenatal diagnosis centre. * Patients who had attended at least one antenatal consultation with a pediatric neonatologist * Patients who gave birth between January 2020 and December 2022 and whose newborn was hospitalized in the neonatology department Exclusion Criteria: * a child who died in hospital or had a condition with a high risk of death in the first few years of life * non-French speaking mothers * Mothers who were minors at the time of the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Femme Mère Enfant Hospital (HFME) Bron France Recruiting

More Hospices Civils de Lyon trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06820892 on ClinicalTrials.gov ↗ ← All trials in France